\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Events

LifeSci Partners Precision Oncology Day
 February 17, 2021
 10:30am - 11:00am PST

A replay of the presentation will be available and will be archived for 90 days.by clicking on the following link:  https://wsw.com/webcast/lifesci2/crdf/2109071